4093.T
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. 4093.T is a commodity chemicals company operating within the broader chemicals industry. The firm generates revenue through the sale of commodity-grade chemicals and branded specialty formulations. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
4093.T is a commodity chemicals company operating within the broader chemicals industry. The firm generates revenue through the sale of commodity-grade chemicals and branded specialty formulations. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥9.5 billion, representing 28.2% of total assets. Its liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of ¥826 million and total liabilities of ¥15.3 billion, indicating a low liquidity risk. The current ratio of 1.79 further supports its ability to meet short-term obligations.
Profitability metrics show a return on equity (ROE) of 6.9% and a return on assets (ROA) of 3.76%. These figures are below the industry median for ROE and ROA, which are typically higher for firms in the Commodity Chemicals sector due to the capital-intensive nature of the industry. The company's gross margin of 31.5% is in line with the sector median, but its operating margin of 5.4% is below average, indicating potential inefficiencies in cost management or pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdown in the financial data suggests a need for further transparency in the company's disclosures.
Looking ahead, the company is projected to experience modest revenue growth, with a year-over-year increase of approximately 2.5% in the current fiscal year and a 3.0% increase in the following year. These growth rates are in line with the industry average, but the company's capital expenditure of ¥777 million indicates a focus on maintaining rather than expanding production capacity.
Risk factors include a low liquidity risk and a low dilution risk, as no immediate filing-based liquidity or dilution flags were detected. The company's debt-to-equity ratio of 0.21 is well below the industry median, suggesting a conservative capital structure. However, the low price-to-book ratio of 0.75 indicates that the market may be undervaluing the company's tangible assets.
Recent events include the filing of the latest financial results, which show a net income of ¥1.26 billion and an operating income of ¥1.89 billion. These results were in line with analyst estimates for revenue and EPS, suggesting stable performance. No significant new product launches or strategic acquisitions were disclosed in the latest filings.
- The company maintains a strong liquidity position with a current ratio of 1.79 and ¥9.5 billion in cash and equivalents.
- Profitability metrics are below the industry median, with a ROE of 6.9% and a ROA of 3.76%.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company is projected to experience modest revenue growth of 2.5% in the current fiscal year and 3.0% in the following year.
- The company has a conservative capital structure with a debt-to-equity ratio of 0.21 and a low dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 4093.T Market data — financials · 2026-05-26
- Toho Acetylene Co Ltd Market data — analyst estimates · 2026-05-26